COPD Exacerbations: Clinical Trials

3 trials for COPD Exacerbations, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 unknown. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Not yet recruiting 1

Follow COPD Exacerbations: new trials by email Literature Review of COPD Exacerbations trials Research Report on COPD Exacerbations

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The REVIVE Pivotal Study
Ryme TLD, Sham Control - COPD (Chronic Obstructive Pulmonary Disease), COPD Exacerbations
Not applicableNot yet recruitingRyme Medical, Inc.3002026-06-012026-05-05
HFNC vs. NIV in Acute COPD Exacerbations
NIV, HFNC-30, HFNC-50 - COPD Exacerbations, Acute Hypercapnic Respiratory Failure
Not applicableCompletedHaseki Training and Research Hospital1372023-09-012024-07-10
Hospitalary Chronic Obstructive Pulmonary Disease Registry
COPD Exacerbations, Death
UnknownHospital Italiano de Buenos Aires3002016-07-012019-08-13

Narrower conditions

Death (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Respiratory Insufficiency (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiratory Tract Diseases (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Respiration Disorders (1)

Sponsors

Haseki Training and Research Hospital (1)  ·  Hospital Italiano de Buenos Aires (1)  ·  Ryme Medical, Inc. (1)

Countries

Argentina (1)  ·  Turkey (Türkiye) (1)

Top investigators

Adem Az, M.D. (1)  ·  Diego H Giunta, MD (1)

Results publications

PMID 31641959, PMID 33269553, PMID 33317579, PMID 36581995, PMID 39481328